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Abstract
Background: In 2007–2008, two UK-based organisations, the National Institute for Health and Clinical Excellence
and the Royal College of Obstetricians and Gynaecologists, published guidelines for the management of care and
organisation of outpatient services for women with heavy menstrual bleeding (HMB). In 2010, this study was
conducted to provide an update on guideline-related services provided in England and Wales, and whether they
are consistent with national clinical guidelines two to three years after publication.
Methods: An organisational survey of outpatient gynaecology clinics was conducted of 221 hospitals in 154 acute
National Health Service (NHS) trusts in England and Wales. A questionnaire was distributed to all hospitals to
examine provision of diagnostic and therapeutic services in outpatient settings. Descriptive statistics were used to
summarize results.
Results: The response rate was 100%. For diagnosis, 80% of hospitals had ultrasound, 87% had hysteroscopy, and
98% had endometrial biopsy available. Overall, 76% of hospitals provided an information leaflet, 8% referred
patients to a website for information, and 20% did not provide any written information. A dedicated menstrual
bleeding clinic was present in 38% of hospitals. Only 30% of hospitals reported that they have a local written
protocol regarding the care and management of women with HMB.
Conclusion: The majority of hospitals offer appropriate diagnostic and surgical services for women with HMB.
However, local protocol development may not reflect the local services. It may be that hospitals are finding it
difficult to summon resources to provide clinics for women with menstrual disorders.
Keywords: Heavy menstrual bleeding, Menorrhagia, Gynaecology, Health services, National guidelines
Background
Heavy menstrual bleeding (HMB) is estimated to affect ap-
proximately 5% to 30% of women of reproductive age. It is
the fourth most common cause for referral to gynaeco-
logical services in the UK [1,2]. HMB is a condition that
significantly impacts women’s perceived physical and men-
tal health over time (health-related quality of life) [3,4]. Be-
tween 2004 and 2006, there were 51,664 women with HMB
aged between 25 and 59 years who underwent either an
endometrial ablation or hysterectomy in English National
Health Service (NHS) trusts [5]. Among women with
HMB, surgical rates across English regions (defined by Stra-
tegic Health Authorities, SHAs) ranged from 52 to 230 pro-
cedures per 100,000 women [5].
In 2007, the National Institute for Health and Clinical
Excellence (NICE) published Heavy Menstrual Bleeding, a
national guideline on the management of HMB [6]. In
2008, the Royal College of Obstetricians and Gynaecolo-
gists (RCOG) also issued HMB-specific recommendations
in their Standards of Gynaecology [7]. Despite this, signifi-
cant regional variation in surgical treatment rates did not
diminish between 2006 and 2009 [8].
The guidelines make various recommendations about
the organisation of outpatient gynaecology services for
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women with HMB. These recommendations cover struc-
tural issues such as the creation of dedicated one-stop
menstrual bleeding clinics, which include diagnostic facil-
ities within the clinic, to the provision of HMB-specific
health and treatment information to patients.
One potential explanation for the regional differences
in surgical treatment rates of women with HMB was the
variation in the organisation of gynaecological outpatient
services and the degree to which guideline recommenda-
tions had been adopted. We therefore conducted an or-
ganisational survey of outpatient services for HMB in
NHS hospitals in England and Wales, which was part of
a larger ongoing project commissioned by the Health-
care Quality Improvement Partnership as part of the Na-
tional Clinical Audit and Patient Outcomes Programme
[9,10]. The organisational survey reported here exam-
ined the local provision of diagnostic and therapeutic
services, local protocols for the management of HMB
and issues related to referral patterns from primary care.
Methods
All 221 NHS hospitals of 154 acute NHS trusts in England
and Wales providing secondary care through outpatient
gynaecology departments during June to September 2010
were eligible to participate. The hospitals were identified
from various sources including the RCOG database of
Clinical Directors and the NHS service provider web-
sites for England (nhs.uk) and Wales (wales.nhs.uk). In
accordance with current guidelines on clinical audit, no
ethical committee review was required for the conduct
of this project.
The questionnaire included items on various aspects of
the NICE and RCOG guidelines, and practical aspects of
service provision (Table 1). In addition, the hospitals were
asked to return a copy of any and all local guidelines or
protocols regarding the care and management of women
with HMB. The questionnaire was designed in consult-
ation with an Expert Advisory Group consisting of
healthcare consumers and clinical representatives from
gynaecology, nursing, general practice, psychology, and
health services research. The survey questionnaire was
created in both a paper-based and a web-based format.
Both were piloted at six hospitals across England and
Wales and updated in response to the comments from
these pilot sites.
Hospitals were approached through the Clinical Direc-
tors of Obstetrics and Gynaecology or the Clinical Audit
Departments. The person nominated to complete the
questionnaire received their preferred questionnaire for-
mat. Up to three reminders were sent at approximately
three week intervals after the initial distribution, and re-
spondents could contact the study team to answer queries.
All analyses used descriptive statistics to summarise
responses to the survey.
Results
All 221 hospitals returned the questionnaire (response rate
of 100%). Data completeness was very high with only 1-3%
missing values for the questions reported here.
Availability of hospital facilities
The majority of hospitals reported having access to the
principal diagnostic facilities within their department to in-
vestigate patients with HMB. Overall, 98% (216/221) had
access to endometrial biopsy, 80% (177/221) had ultra-
sound, and 87% (193/221) had hysteroscopy. In addition,
95% of hospitals (210/221) reported that they had “day care
diagnosis” available, which combines inpatient-based hys-
teroscopy with endometrial biopsy. 38% of hospitals (84/
219) reported they ran a dedicated menstrual bleeding
clinic, of which 73 were described as a “one-stop” clinic
that provided both diagnosis and treatment plan at the
same appointment. Access to diagnostic facilities was
slightly better in hospitals with these dedicated clinics
(Table 2).
All hospitals reported that endometrial ablation and
hysterectomy were available surgical options. One or
more second-generation ablation techniques were of-
fered by 94% (207/221) of hospitals, of which fluid filled
thermal balloon ablation was the most commonly avail-
able. Over 70% (158/221) of hospitals still offered the
first-generation roller ball ablation technique, but only
5% (11/221) of hospitals offered this technique as their
only ablation option.
Patient management within outpatient departments
Hospitals were asked what investigations are considered at
the initial consultation in their clinic for women with HMB
being referred for the first time. In general, the responses
followed the national recommendations (Table 3) [1,2]. An
abdominal and pelvic examination was considered ‘mostly’
or ‘always’ by 99% (219/221) of hospitals, while an objective
measurement of blood loss was ‘never’ or ‘rarely’ considered
by 82% (181/220) of hospitals.
Availability of patient information varied among res-
ponding hospitals, as 76% (165/217) provided an informa-
tion leaflet, while 8% (18/217) referred patients to a
website for information. 20% (43/217) of hospitals did not
provide written information.
Only 6% (13/221) of hospitals reported that they for-
mally assess how HMB affects women’s lives using a
quality of life instrument. The questionnaire could be
sent prior to the first visit, or completed during or after
the first visit.
Overall, 30% (64/214) of hospitals reported that they
have a written local protocol on the management of
women with HMB.
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Table 1 Questionnaire design for the organisational survey of gynaecological outpatient services for heavy
menstrual bleeding
Domain Topic
Services and care for women with
Heavy Menstrual Bleeding (HMB)
• Local written protocol or guideline for HMB*
◦ Local protocols derived from national guidelines should be in place for speedy and
evidence-based management of heavy menstrual bleeding in primary care. (RCOG)
• Dedicated menstrual bleeding clinic*
◦ There should be a dedicated one-stop menstrual bleeding clinic with facilities within
the clinic for diagnostic gynaecology, including hysteroscopy and ultrasound. (RCOG)
• If yes, is the clinic ‘one-stop’ (i.e., a clinic designed only to see patients with menstrual bleeding issues)?*
◦ There should be a dedicated one-stop menstrual bleeding clinic with facilities within
the clinic for diagnostic gynaecology, including hysteroscopy and ultrasound. (RCOG)
• Facilities available within the department
• Investigations at first consultation
• Surgical treatment options*
◦ In women with HMB alone, with uterus no bigger than a 10-week pregnancy,
endometrial ablation should be considered preferable to hysterectomy. (NICE)
Referral to secondary care • Referral system in the local area*
◦ Referral pathways between primary and secondary care should be agreed locally and reviewed annually. (RCOG)
• Baseline investigations generally carried out in primary care
• Treatment offered in primary care*
◦ Adequate facilities and trained individuals should be available for the insertion of levonorgestrel-releasing
intrauterine system (LNG-IUS) in the outpatient clinic and in primary care settings. (RCOG)
• Proportion of women with no treatment in primary care*
◦Adequate facilities and trained individuals should be available for the insertion of levonorgestrel-releasing
intrauterine system (LNG-IUS) in the outpatient clinic and in primary care settings. (RCOG)
• Reasons for referral to secondary care
• Average waiting time from referral to appointment
• Management options in secondary care
• Direct GP referral to diagnostic procedures*
◦ Guidelines should be in place for direct referral to imaging services from primary care. (RCOG)
Information for patients • Written information for patients about HMB*
◦ An information leaflet should be available that includes each treatment option for heavy
menstrual bleeding, together with outcomes and complications. (RCOG)
◦ A woman with HMB referred to specialist care should be given information before her
outpatient appointment. The Institute’s information for patients (‘Understanding NICE guidance’)
is available from www.nice.org.uk/CG044publicinfo (NICE)
• Timing of information
• Who provides it
Patient questionnaires • Formal questionnaire to assess how HMB affects women*
◦ For clinical purposes, HMB should be defined as excessive menstrual blood loss which interferes with the
woman’s physical, emotional, social and material quality of life, and which can occur alone or in combination
with other symptoms. Any interventions should aim to improve quality of life measures. (NICE)
◦ The treatment should aim to improve quality of life rather than focusing on menstrual blood loss alone. (RCOG)
• Timing of questionnaire
• Who provides it
Departmental information • Number of first appointments in clinic overall
• Number of first appointments for HMB
*Relevant guideline in Standards for Gynaecology, RCOG 2008, or Heavy Menstrual Bleeding, NICE 2007.
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Treatment in primary care and reasons for referral
Respondents reported on the investigations that had typic-
ally been performed in primary care before women were
referred to their secondary care clinics (Table 4). Full
blood count was the most commonly reported investiga-
tion in primary care with 94% (207/220) of hospitals
reporting that this was ‘always,’ ‘mostly’ or ‘sometimes’ per-
formed. 99% of hospitals (218/220) responded that Gen-
eral Practitioners (GPs) in their area could refer directly to
imaging services. It was less common for GPs to be able
to refer directly to pathology (in 42% of hospitals [94/
220]) and other diagnostic procedures (in 22% of hospitals
[48/220]).
There were 83% (181/218) of hospitals that reported
over half of their patients had received some treatment in
primary care, with tranexamic or mefanamic acid being
most common (Table 5). Nonetheless, 17% of hospitals
(37/218) reported that most or almost all of their patients
did not receive any treatment in primary care.
Hospitals were also asked the most common reasons
why patients with HMB would be referred for the first
time to their outpatient department. ‘Failure to respond to
medical treatment in primary care’ was the most common
reason (98% [214/219] responded this was ‘always,’ ‘mostly’
or ‘sometimes’ the case). ‘Patient was seeking a definite
treatment such as hysterectomy’ was also common (94%
[205/218] responded this was ‘always,’ ‘mostly’ or ‘some-
times’ the case). ‘Patient requesting referral to a specialist’
was slightly less common (86% [180/210]).
Discussion
The organisational survey presented here sought to an-
swer the question as to whether outpatient care for
women with HMB currently met national guidelines,
which had been developed by NICE and RCOG in re-
sponse to “a lack of consensus about the best form of
management of this condition” [6,7,11]. This organisa-
tional survey is the first step of a larger project that will
collect information on the patient-reported outcomes of
care for women with HMB in the first year after their
first outpatient visit at NHS hospitals in England and
Wales [9,10].
To adequately provide a national picture, the extent of
coverage is critical for any national survey [12]. While we
acknowledge that some specialised care for women with
HMB may be provided by specialty primary care clinics or
other women’s health clinics provided by the private sec-
tor, this national survey comprehensively describes the or-
ganisation of outpatient care in the NHS across England
and Wales.
A limitation of the study design is the difficulty in
translating national guidelines into survey questions.
Many of the guidelines’ recommendations are very spe-
cific in the relationship between symptomology and re-
sultant treatment options. Therefore, the organisational
survey was limited to general issues such as the availabil-
ity of diagnostic equipment, the availability of various
treatment options, and referral patterns from primary to
secondary care. In addition, for some survey items, yes-
no questions (e.g., Does your hospital have a one-stop
clinic?) rather than the implementation rates (e.g., What
percentage of patients are able to access a one-stop
clinic?) were asked. This limitation in precision of meas-
urement was part of the design strategy wherein ease
and accuracy of question completion was prioritised. The
result allowed for measurement of whether hospitals had
Table 2 Available facilities within gynaecology outpatient departments for diagnosis and treatment of heavy
menstrual bleeding
Facilities No dedicated menstrual
bleeding clinic
Dedicated menstrual
bleeding clinic
Ultrasound (trans-vaginal scanning in the clinic) 75.6% (102/135) 88.1% (74/84)
Hysteroscopy (outpatient based) 80.0% (108/135) 98.8% (83/84)
Endometrial biopsy (outpatient based) 96.3% (130/135) 100.0% (84/84)
Day care diagnosis (inpatient-based) hysteroscopy plus endometrial biopsy 95.6% (129/135) 94.0% (79/84)
Table 3 Investigations considered at first outpatient gynaecology visit for women with heavy menstrual bleeding
Always(%) Mostly(%) Sometimes(%) Rarely(%) Never(%) Responses(n)
Abdominal and pelvic examination 83.7 15.4 0.9 0.0 0.0 221
Full blood count test 24.3 36.9 32.7 6.1 0.0 214
Ultrasound and other imaging 29.4 41.2 27.6 1.4 0.5 221
Pathology (e.g., endometrial biopsy) 8.7 42.0 47.0 1.8 0.5 219
Objective method of assessing blood loss 5.0 7.7 5.0 28.2 54.1 220
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at least met the minimum level of the recommendation
(e.g., setting up a one-stop clinic).
While an in-person audit of available services would
have been an ideal way to measure adherence to recom-
mendations, cost constraints limited the study to a self-
report survey design. Whenever possible, reliability of
responses was verified by asking Clinical Directors to
oversee the completion of the survey; by engaging local
Clinical Audit Departments; and by clarifying survey re-
sponses with hospital staff.
In their standards, the RCOG emphasises that “every
organisation should clearly set out specific requirements
relating to the management of excessive menstrual blood
loss which interferes with a woman’s physical, social,
emotional and material quality of life.” Hospitals were
therefore asked whether their hospital had a local,
written protocol. Surprisingly, less than one in three
hospitals reported that they had such a protocol.
Another recommendation of the RCOG is that “there
should be a dedicated one-stop menstrual bleeding clinic
with facilities within the clinic for diagnostic gynaecol-
ogy, including hysteroscopy and ultrasound.” This rec-
ommendation is aimed at streamlining services and
reducing the burden on both health professionals’ and
patients’ time. Again, only about one in three hospitals
reported that this type of clinic was available. A similar
proportion reported having a dedicated menstrual disor-
ders clinic. This kind of clinic could be very beneficial to
patients’ experience of care.
One in five hospitals reported that they do not provide
an informational leaflet nor refer patients to a website. This
is a remarkable observation as high-quality informational
materials about HMB and its treatment options is readily
available (see for example http://guidance.nice.org.uk/
CG44/PublicInfo/doc/English).
Encouragingly, many of the diagnostic and thera-
peutic recommendations in the national guidelines are
being met by most hospitals. For example, almost all
hospitals (99%) reported that GPs in their area could
refer directly to imaging services. Similarly, almost all
hospitals (94%) offer one or more second-generation
ablation techniques.
Conclusions
The national survey of hospitals in England and Wales
showed that basic care provision for women with HMB is
being met through adequate levels of diagnostic and treat-
ment facilities. However, key systems such as local proto-
cols (which put in place agreements regarding referral and
management of patients) and one-stop menstrual disor-
ders clinics (which would streamline care and improve the
care experience of patients with HMB) were reported by a
minority of hospitals.
The National HMB Audit, a prospective national clinical
audit collecting information reported by women who visit
the outpatient gynaecology department of NHS hospitals
in England and Wales for the first time is currently being
carried out (http://www.rcog.org.uk/orca/audit). This audit
aims to assess whether care and management of women
with HMB can be further improved. It will provide key in-
formation on the impact that variations of service
provision have on the outcomes of secondary care in terms
of symptom severity and quality of life.
Table 4 Primary care investigations for heavy menstrual bleeding before referral to outpatient gynaecology
(reported by hospital)
Always(%) Mostly(%) Sometimes(%) Rarely(%) Never(%) Don’t know(%) Responses(n)
Full blood count 3.6 48.2 42.3 5.9 0.0 0.0 220
Ultrasound 2.3 18.6 73.5 5.6 0.0 0.0 215
Thyroid function test 0.0 6.4 58.6 31.4 3.2 0.5 220
Hormonal assessment 0.0 4.6 51.6 40.1 3.7 0.0 217
Liver function test 0.0 0.5 8.1 56.9 34.0 0.5 209
Table 5 Primary care treatments prior to referral to an outpatient gynaecology department (reported by hospital)
Treatment Always(%) Mostly(%) Sometimes(%) Rarely(%) Never(%) Responses(n)
Tranexamic acid 1.4 36.4 60.5 1.8 0.0 220
Trial of treatment with mefenamic acid 2.3 28.2 65.5 4.1 0.0 220
Oral progestogens 0.5 12.4 68.7 18.0 0.5 217
Combined oral contraceptives (COCs) 0.9 6.4 77.2 15.1 0.5 219
Levonorgestrel-releasing intrauterine system (LNG-IUS) (e.g., Mirena) 0.0 4.6 67.0 24.8 3.7 218
Injected long-acting progestogens 0.0 1.9 47.4 48.8 1.9 215
Self-treatment 1.9 3.2 31.2 54.1 9.6 157
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